Randomized Trial of Interventions to Improve Childhood Asthma in Homes with Wood-Burning Stoves by Noonan, Curtis W. et al.
University of Kentucky
UKnowledge
Statistics Faculty Publications Statistics
9-13-2017
Randomized Trial of Interventions to Improve
Childhood Asthma in Homes with Wood-Burning
Stoves
Curtis W. Noonan
University of Montana
Erin O. Semmens
University of Montana
Paul Smith
University of Montana
Solomon W. Harrar
University of Kentucky, solomon.harrar@uky.edu
Luke Montrose
University of Montana
See next page for additional authors
Right click to open a feedback form in a new tab to let us know how this document benefits you.
Follow this and additional works at: https://uknowledge.uky.edu/statistics_facpub
Part of the Environmental Health Commons, and the Statistics and Probability Commons
This Article is brought to you for free and open access by the Statistics at UKnowledge. It has been accepted for inclusion in Statistics Faculty
Publications by an authorized administrator of UKnowledge. For more information, please contact UKnowledge@lsv.uky.edu.
Repository Citation
Noonan, Curtis W.; Semmens, Erin O.; Smith, Paul; Harrar, Solomon W.; Montrose, Luke; Weiler, Emily; McNamara, Marcy; and
Ward, Tony J., "Randomized Trial of Interventions to Improve Childhood Asthma in Homes with Wood-Burning Stoves" (2017).
Statistics Faculty Publications. 19.
https://uknowledge.uky.edu/statistics_facpub/19
Authors
Curtis W. Noonan, Erin O. Semmens, Paul Smith, Solomon W. Harrar, Luke Montrose, Emily Weiler, Marcy
McNamara, and Tony J. Ward
Randomized Trial of Interventions to Improve Childhood Asthma in Homes with Wood-Burning Stoves
Notes/Citation Information
Published in Environmental Health Perspectives, v. 125, no. 9, 097010, p. 1-9.
EHP is an open-access journal published with support from the National Institute of Environmental Health
Sciences, National Institutes of Health. All content is public domain unless otherwise noted.
Digital Object Identifier (DOI)
https://doi.org/10.1289/EHP849
This article is available at UKnowledge: https://uknowledge.uky.edu/statistics_facpub/19
Randomized Trial of Interventions to Improve Childhood Asthma in Homes with
Wood-burning Stoves
Curtis W. Noonan,1 Erin O. Semmens,1 Paul Smith,1,2 Solomon W. Harrar,3,4 Luke Montrose,1 Emily Weiler,1
Marcy McNamara,1 and Tony J. Ward1
1School of Public and Community Health Sciences, University of Montana, Missoula, Montana, USA
2Community Medical Center, Missoula, Montana, USA
3Department of Statistics, University of Kentucky, Lexington, Kentucky, USA
4Department of Mathematical Sciences, University of Montana, Missoula, Montana, USA
BACKGROUND: Household air pollution due to biomass combustion for residential heating adversely affects vulnerable populations. Randomized con-
trolled trials to improve indoor air quality in homes of children with asthma are limited, and no such studies have been conducted in homes using
wood for heating.
OBJECTIVES: Our aims were to test the hypothesis that household-level interventions, specifically improved-technology wood-burning appliances or
air-filtration devices, would improve health measures, in particular Pediatric Asthma Quality of Life Questionnaire (PAQLQ) scores, relative to pla-
cebo, among children living with asthma in homes with wood-burning stoves.
METHODS: A three-arm placebo-controlled randomized trial was conducted in homes with wood-burning stoves among children with asthma.
Multiple preintervention and postintervention data included PAQLQ (primary outcome), peak expiratory flow (PEF) monitoring, diurnal peak flow
variability (dPFV, an indicator of airway hyperreactivity) and indoor particulate matter (PM) PM2:5.
RESULTS: Relative to placebo, neither the air filter nor the woodstove intervention showed improvement in quality-of-life measures. Among the sec-
ondary outcomes, dPFV showed a 4.1 percentage point decrease in variability [95% confidence interval ðCIÞ= − 7:8 to −0:4] for air-filtration use in
comparison with placebo. The air-filter intervention showed a 67% (95% CI: 50% to 77%) reduction in indoor PM2:5, but no change was observed
with the improved-technology woodstove intervention.
CONCLUSIONS: Among children with asthma and chronic exposure to woodsmoke, an air-filter intervention that improved indoor air quality did not
affect quality-of-life measures. Intent-to-treat analysis did show an improvement in the secondary measure of dPFV.
Trial registration: ClincialTrials.gov NCT00807183. https://doi.org/10.1289/EHP849
Introduction
Several studies of children with asthma in urban environments
have targeted the household environment to improve health out-
comes (Bryant-Stephens 2009; Butz et al. 2011; Eggleston et al.
2005; Krieger et al. 2005; Levy et al. 2006; Morgan et al. 2004;
Sweet et al. 2014). These intervention studies have targeted asthma
triggers by employing education strategies and/or directly mitigating
exposure to allergens through pest management and/or use of
allergen-impermeable mattress and pillow encasings. Three of these
studies incorporated air-filter devices in the intervention strategy to
reduce children’s exposure to airborne allergens, dust, or environ-
mental tobacco smoke (Butz et al. 2011; Eggleston et al. 2005;
Morgan et al. 2004). The intervention strategies consistently demon-
strated declines in asthma-related symptom measures. However, all
of these studies were conducted in urban environments, and the na-
ture of these exposures likely differ from that of exposures in rural
environments.
Attention to home heating sources in asthma intervention trials
has been limited. One randomized trial showed lower frequency of
asthma symptoms and health care visits compared with controls
when improved heating-source interventions were employed to
increase indoor temperature and decrease NO2 concentrations
(Howden-Chapman et al. 2008). To our knowledge, no randomized
controlled trials among children with asthma have been conducted
that target indoor particulate matter (PM) exposures in rural-area
homesheatedby residentialwoodstoves.
Biomass combustion is known to be an important contributor
to household air pollution in developing countries with resultant
adverse health effects (Smith et al. 2014). The exposure scenarios
and health consequences related to biomass combustion in
developing-country settings are distinct from those in high-
income countries. Nevertheless, burning wood for residential
heating is an important PM exposure source in many developed
countries, particularly in rural settings. The U.S. Department of
Energy estimates that there are 11:6million homes that use wood
as a primary or secondary heating fuel (U.S. Department of
Energy 2009), translating to more than three million children liv-
ing in woodstove-heated homes (Noonan et al. 2015). Estimates
of the contribution of wood-burning to ambient air quality can
vary widely (Naeher et al. 2007), but woodsmoke accounts for
80– 90% of the ambient PM concentrations in communities with
a high proportion of wood-burning households (Johnston et al.
2013; McGowan et al. 2002; Ward and Lange 2010; Ward et al.
2006). In the European Union, it is estimated that domestic
woodstoves will be the dominant source of ambient fine PM
(PM2:5), accounting for 38% of all emissions by 2020 (Sigsgaard
et al. 2015).
Indoor PM2:5 concentrations in homes that heat with wood of-
ten exceed the World Health Organization daily ambient air-
quality standard of 25lg=m3 (Noonan et al. 2012; Semmens
et al. 2015; Ward et al. 2011), likely the result of indoor PM sour-
ces and infiltration of ambient PM from local sources (Allen
et al. 2003; Barn et al. 2008; Hystad et al. 2009; Semmens et al.
2015). Few exposure-reduction interventions have been tested in
Address correspondence to C.W. Noonan, School of Public and Community
Health Sciences, 32 Campus Dr., University of Montana, Missoula, MT
59812 USA. Telephone: (406) 243-4957; Fax: (406) 243-2807. Email: curtis.
noonan@umontana.edu
Supplemental Material is available online (https://doi.org/10.1289/EHP849).
The authors declare they have no actual or potential competing financial
interests.
Received 21 July 2016; Revised 13 June 2017; Accepted 16 June 2017;
Published 13 September 2017.
Note to readers with disabilities: EHP strives to ensure that all journal
content is accessible to all readers. However, some figures and Supplemental
Material published in EHP articles may not conform to 508 standards due to
the complexity of the information being presented. If you need assistance
accessing journal content, please contact ehponline@niehs.nih.gov. Our staff
will work with you to assess and meet your accessibility needs within
3 working days.
Environmental Health Perspectives 097010-1
A Section 508–conformant HTML version of this article
is available at https://doi.org/10.1289/EHP849.Research
such wood-burning households (Allen et al. 2011; Noonan et al.
2012; Ward et al. 2011), and none has been evaluated in the con-
text of impact on children’s health.
We report here results from a randomized controlled trial to
evaluate interventions targeting biomass smoke PM from older-
model residential woodstoves in homes of children with asthma.
Older-model stoves are models defined as not being certified by the
U.S. Environmental Protection Agency (EPA), or those that have
emissions of >4:1 grams=hour of PM for a catalytic stove or
7:5 grams=hour for a noncatalytic stove. The Asthma Randomized
Trial of Indoor Wood Smoke (ARTIS) took place in rural areas of
Montana, Idaho, and Alaska, where residential wood combustion is a
major source of ambient and indoor PM2:5 and the primary source of
home heating during cold-temperature periods. Our aims were to test
the hypothesis that (a) improved-technology wood-burning stoves or
(b) air-filtration units would result in improvements, relative to pla-
cebo, in asthma measures among children in participating homes.
Methods
Study Overview
The ARTIS study design has been previously described (Noonan
and Ward 2012). Briefly, ARTIS was a three-arm randomized
placebo-controlled intervention trial with two intervention strat-
egies for reducing in-home woodsmoke PM (Figure 1). Eligible
participants were identified by parent-response screening ques-
tionnaire (Magzamen et al. 2005) and included children with
asthma, age 6–18 y, residing in a non-tobacco-smoking house-
hold that used an older-model woodstove as their primary
source of heating. If a household had more than one eligible
child with asthma, the child with more severe asthma based on
screening questions was designated as the primary participant in
the household, but all eligible, consented children with asthma
were included in the analyses. Overall, ARTIS was conducted
over five years. Each household participated in two consecutive
winter periods with household interventions occurring between
the two winter periods (Figure 2). Homes were randomly
assigned to one of three treatments: the woodstove-intervention
group receiving improved-technology wood-burning appliances
(i.e., EPA-certified woodstoves), the air-filter group receiving
functioning air-filtration devices, and the placebo group receiving
sham air-filtration devices. Detailed specifications of the interven-
tion treatments can be found in Supplemental Material. This study
was approved by the University of Montana Institutional Review
Board. Participating children completed documented assent proce-
dures, and a parent or guardian signed parental permission forms.
Health Measures
The primary health outcome was change in the score on the
Pediatric Asthma Quality of Life Questionnaire (PAQLQ) admin-
istered directly to children at each visit. The PAQLQ is a 23-item
asthma-specific battery that provides an overall score as well as
domain scores for symptoms (10 items), activity limitation (5
items), and emotional function (8 items) (Juniper et al. 1996).
The instrument requires the participating children to reflect on
the experiences over the prior week; thus, it is a one-week retro-
spective self-assessment (Figure 3). This instrument has strong
correlation, both longitudinal and cross-sectional, with other
measures of asthma severity, such as peak flow monitoring, med-
ication use, and symptom diaries, among children with asthma
ages 7 through 17 y (Juniper et al. 1996). The score for each do-
main is the average of the items in it, with scores ranging from 1
to 7 (with 7 as the optimal score), and the overall PAQLQ score
was the mean score across the three domains. The primary hy-
pothesis was that the preintervention to postintervention change
in PAQLQ scores would be greater in the woodstove changeout
or air filter arms relative to placebo. Our a priori power estimates
indicated that when comparing two groups, a sample size of 30
subjects per group would provide 80% power to demonstrate a
difference in PAQLQ scores of 1.0 unit or greater at the 95% con-
fidence level (CI).
Figure 1. Trial profile. Note: The woodstove changeout arm (W) was dis-
continued prior to recruiting the final cohort of homes.
Figure 2. Study locations according to years of participation. Note: The
woodstove changeout arm (W) was discontinued prior to recruiting the
final cohort of homes. F, air filter arm; W, woodstove changeout arm; P,
placebo arm.
Figure 3. Schematic of sampling visit. Each visit occurred multiple times
during each of two winter periods, a preintervention winter and a postinter-
vention winter. For a given visit, study personnel administered the PAQLQ
to participants. The PAQLQ is a self-assessment questionnaire reflecting on
the child’s past week of experiences. At the sampling visit, children are
trained in the use of the expiratory flow monitor and begin recording twice-
daily measures of PEF and FEV1 for two weeks. Indoor air monitoring was
initiated on Day 0 and continued for 48 h. Note: FEV1, forced expiratory
volume in the 1st second; PAQLQ, pediatric asthma quality of life question-
naire; PEF, peak expiratory flow.
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Secondary outcomes included home-based peak flow moni-
toring. Parents and children were trained to collect twice-daily
measures (in the morning and in the evening) of peak expiratory
flow (PEF) and forced expiratory volume in the first second
(FEV1) using the PiKo-1 Peak Flow Meter (Ferraris). These
measures were collected and logged during a two-week period
beginning with the first day of an exposure sampling visit. For
each measure, the child performed a peak flow maneuver three
times, and the device stored the best result for PEF and FEV1.
Outcomes from these two-week recordings included average per-
cent predicted morning PEF and FEV1, average percent predicted
evening PEF and FEV1, and average diurnal PEF variability
(dPFV). Daily dPFV was the amplitude as a percentage of the
mean of consecutive evening to morning readings, or (previous
night PEF–morning PEF)/(mean of the two measures) (Lebowitz
et al. 1997). Whereas lower percent predicted PEF and FEV1 are
considered worse outcomes, the opposite is true for dPFV, where
higher dPFV is considered a worse outcome for children with
asthma.
Additional child data were collected to characterize baseline
health. During each two-week sampling period, parents of partici-
pating children were also asked to record daily health-related
events for their child, including daytime cough or wheezing,
nighttime cough or wheezing, activity limitations due to asthma
symptoms, and use of asthma medications. These data together
with peak-flow monitoring data collected during the baseline
(preintervention) winter were used to classify asthma severity
based on the 2007 National Heart Lung and Blood Institute
(NHLBI) guidelines (National Heart Lung and Blood Institute
2007). For methods used to translate these data to the 2007
NHLBI asthma severity classifications and for overall severity
classification of participants and severity classification according
to specific components, see Supplemental Material and Table S1.
Exposure Assessment
The exposure and health assessments took place on two, 48-h ob-
servation periods during each of two winter periods, before and
after intervention. A DustTrak® Aerosol Monitor 8520/8530
(TSI) was used to continuously measure PM2:5 concentrations
that were corrected for woodsmoke (McNamara et al. 2011). A
Lighthouse 3016-IAQ particle counter (Lighthouse Worldwide
Solutions) was used to continuously measure particle number
concentrations of varying size fractions (0.30–0.49, 0.50–0.99,
1.00–2.49, 2.5–5.0, and 5.0–10.0, 10:0+ lm). Particle number
concentrations (PNCs), reported as the number of particles per
cubic centimeter, were summed across the size fractions
2:5–10:0 lm and were used as a surrogate for concentrations of
coarse PM (PMc). Samplers had 60-s recording intervals, and
were zero calibrated prior to each sampling event. We
included only those 48-h averages that were generated from
data that were at least 80% complete to ensure that the aver-
ages were representative of concentrations experienced during
the entire sampling events. Instrument malfunctions (e.g., flow
errors) or power failures were the primary reasons for sam-
pling events with less than 100% air-sampling data capture.
Prior to sampling, participants completed demographics and
home characteristics surveys. These surveys documented infor-
mation such as household income, education, type/age/size of
home, age of woodstove and specific activities that occurred in
the home during the 48-h sampling periods.
Statistical Analysis
We used analysis of variance or chi-square tests, as appropriate,
to compare differences between treatment groups in descriptive
characteristics such as age, sex, race/ethnicity, and baseline
health measures. We followed the principle of intent-to-treat and
included all participants who were randomized to a treatment arm
and had at least one baseline measure. The objective of our statis-
tical analysis was to evaluate whether intervention assignment
modified the preintervention-to-postintervention winter change in
PAQLQ or peak flow measure. As such, the linear mixed effects
model included fixed effects for a) winter (i.e., preintervention or
postintervention winter), b) intervention assignment (e.g., air fil-
ter), and c) a multiplicative interaction term between these two
variables to assess effect modification by intervention assign-
ment. These models also included fixed effects for age and gen-
der. Initially, random effects were included for both the intercept
and the slope (i.e., winter), which in effect allowed each partici-
pant to have his or her own intercept and slope describing change
in asthma measure from the preintervention to postintervention
winter. However, there were problems with estimation of the
model when we included a random effect for the slope (i.e., win-
ter). As a result, our final model included a random effect only
for the intercept. Winters were nested within participants, and
participants were nested within homes. The linear mixed-model
analysis amounts to adopting likelihood-based available-case
analysis for handling missing data. In post-hoc sensitivity analy-
ses, we examined the impact on results when we adjusted for
additional covariates, including baseline asthma measures, use of
asthma medications, and ambient temperature because these fac-
tors could influence both the use of the woodstove and asthma
measures. We also performed separate analyses for each level of
baseline asthma severity. All intent-to-treat analyses were con-
ducted using SAS (version 9.3; SAS Institute Inc.).
The interventions utilized in this study were designed to
improve various measures of childhood asthma by improving
indoor air quality. Specifically, the objective was to lower con-
centrations of PM2:5 in homes. To assess the extent to which PM
reductions contributed to intervention efficacy, we added both
natural log-transformed PM2:5 and coarse PM as time-dependent
variables to our primary models and examined potential attenua-
tion of efficacy of the interventions. In addition, to examine fur-
ther whether impacts on health were consistent with changes in
PM, we used linear mixed models to assess the effect of PM2:5
concentrations on PAQLQ scores and peak flow measures. These
post-hoc analyses were no longer based on a randomized design
and were adjusted for treatment assignment, gender, and age.
PM2:5 concentrations were skewed and were natural log-
transformed. Thus, results are presented as the change in PAQLQ
or peak flow measure associated with a doubling of PM2:5.
Results
Almost 7,000 recruitment surveys were administered and follow-
up contact with the 408 potentially eligible households resulted
in 115 recruited children with asthma living in 98 eligible house-
holds (Figure 1). Insufficient baseline data were collected for one
participant to classify according to asthma severity, and they
were not included in further analysis. Among the 114 remaining
participants, health and exposure data were captured at 422 over-
all visits (226 during the preintervention winter and 196 during
the postintervention winter). Prior to enrollment of the final
cohort of homes, the woodstove intervention arm was discontin-
ued as interim analyses indicated that the woodstove change-out
was not efficacious in reducing indoor PM2:5 (Ward et al. 2017).
Thus, the sample size in the air filter and placebo arms were
approximately twice that of the woodstove arm.
Descriptive and baseline health characteristics by assigned
treatment arm are shown in Table 1. The overall mean [standard
deviation (SD)] age was 12.4 y (3.0), and 48.3% of participants
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were female. Age, gender, and body mass index were similar
across treatment arms. Most participants were white (82%) and
non-Hispanic (95%), but race and ethnicity were not reported by
parents for seven children. Among those with available race data,
4 of the 41 participants assigned to the air-filter arm were
American Indian/Alaskan Native (AI/AN), and no participants
reported being of AI/AN race in the other two arms. In addition,
101 of the 114 participants (89%) were classified as having
moderate to severe persistent asthma (Table 1 and Table S1). A
majority of caregivers (57%) reported household incomes greater
than $40,000 per year, and 72% reported having some postsecon-
dary education. The majority of homes (87%) reported having a
dog or cat. These factors were similar by treatment arm assign-
ment. During the preintervention winter, overall median PM2:5
concentrations were 17:5 lg=m3, and were higher, relative to pla-
cebo, in homes assigned to the woodstove changeout arm of the
trial. Median PMc was 0.32 particles per cm3 and similar in all
treatment arms.
Among the baseline health measures, averaged over preinter-
vention winter sampling visits, asthma severity and PAQLQ did
not differ among the treatment arms (Table 1). Children in the
woodstove changeout arm had a slightly higher proportion of par-
ticipants experiencing moderate to severe asthma and lower
mean PAQLQ scores. FEV1 and PEF percent predicted were also
lower among participants in the woodstove changeout arm in
comparison with the other study arms. Mean (SD) dPFV during
the preintervention winter was 16.3% (11.1) across treatment
arms.
Within each arm, preintervention to postintervention changes
for PAQLQ and spirometry measures are presented in Table 2.
For all treatment arms, the overall PAQLQ composite score, as
well as domain scores for symptoms, activity limitation, and emo-
tion, increased in magnitude by 0.2–0.7 on the seven-point scale
from one winter to the next. For the spirometry measures,
increases in FEV1 and PEF percent predicted measures would
indicate improvement in lung function, whereas decreases in
dPFV would also indicate improvement in lung function. In gen-
eral, FEV1 and PEF percent predicted measures decreased (i.e.,
worsened) from preintervention to postintervention winters in both
the air-filter and placebo arms. In contrast, dPFV change in the
air-filter arm showed decreased variation, suggesting improved
function with a percentage point change of −2:0 (95%
ðCIÞ= − 4:7 to 0.7), or a 11.8% (95% CI: 27% to −4%) improve-
ment in comparison with baseline in this arm.
Efficacy analyses of preintervention to postintervention changes
in PAQLQ and spirometry measures for treatment arms relative
to placebo are presented in Table 2. Relative to the placebo arm,
the air-filter intervention and the woodstove changeout showed
no improvement in PAQLQ composite or domain scores. Mean
change in PEF and FEV1 were generally better for the air-filter
Table 1. Baseline participant and household characteristics.
Participant characteristics
Woodstove changeout
(n=22)
Air filter
(n=46)
Placebo
(n=46)
Age, mean years (SD) 12.3 (3.1) 12.7 (3.3) 12.2 (2.5)
Body mass index percentile, mean (SD) 67.6 (28.4) 69.7 (27.5) 62.4 (30.1)
Female sex, n (%) 10 (45.5) 25 (54.5) 20 (43.5)
Race, n (%)a
American Indian/Alaskan Native 0 (0.0) 4 (9.8) 0 (0.0)
White 16 (76.2) 32 (78.1) 40 (88.9)
Other 5 (23.8) 5 (12.2) 5 (11.1)
Non-Hispanic ethnicity, n (%)a 20 (95.2) 39 (95.1) 43 (95.6)
Household income ≥$40,000, n (%)a 12 (57) 20 (50) 28 (62)
Household post-secondary education, n (%)a 15 (75) 29 (74) 31 (69)
Dogs or cats in home, n (%) 17 (77) 39 (85) 41 (89)
Baseline (preintervention) Health Measures
Asthma Severity, n (%)
Intermittent or Mild 2 (9.1) 5 (10.9) 6 (13.0)
Moderate or Severe 20 (90.9) 41 (89.1) 40 (87.0)
PAQLQ, mean (SD)
Overall 5.1 (1.0) 5.4 (1.0) 5.4 (1.0)
Symptoms 4.9 (1.2) 5.3 (1.0) 5.3 (1.1)
Limitation of Activity 4.6 (1.3) 5.0 (1.1) 5.0 (1.3)
Emotion 5.7 (0.8) 5.6 (1.1) 5.7 (1.0)
Two-week spirometry monitoring, mean (SD)
Evening FEV1 percent predicted 75.3 (19.0) 87.2 (18.1) 88.3 (24.9)
Morning FEV1 percent predicted 73.1 (19.4) 86.2 (18.2) 87.5 (24.4)
Evening PEF percent predicted 72.4 (25.8) 84.9 (24.7) 85.1 (21.9)
Morning PEF percent predicted 70.8 (25.6) 82.3 (22.8) 82.9 (23.0)
Diurnal PEF variability (dPFV), % 18.5 (8.5) 17.0 (10.4) 14.4 (6.3)
Two-week reporting of symptoms and medical usage
Daytime cough/wheezing, days
Mild 5.7 (3.8) 4.3 (3.2) 4.2 (3.1)
Moderate/Severe 1.9 (2.9) 1.0 (1.5) 0.9 (1.6)
Nighttime cough/wheezing, days
Mild 3.2 (3.0) 2.6 (2.7) 3.3 (3.0)
Moderate/Severe 2.9 (4.6) 0.8 (1.4) 0.9 (1.6)
Altered activity/behavior, days
Mild 3.8 (2.9) 2.0 (2.3) 2.1 (2.4)
Moderate/Severe 1.3 (1.9) 0.8 (1.4) 1.0 (2.4)
Medication usage, doses
Long-term control medications 4.4 (6.2) 7.5 (10.6) 4.0 (7.4)
Quick relief medications 4.9 (7.1) 4.1 (7.9) 3.8 (6.4)
Note: FEV1, forced expiratory volume in the first second; PAQLQ, pediatric asthma quality of life; PEF, peak expiratory flow.
aRace/ethnicity, household income, and household education not reported for 7, 8, and 10 participant parents, respectively.
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and woodstove changeout arms, in comparison with the placebo
arm. For example, change (and 95% CI), relative to placebo, in
morning percent predicted PEF were 3.4 (−4:1 to 11) and 7.8
(−1:6 to 17) for air-filter and woodstove changeout arms, respec-
tively. Observations for dPFV showed lesser variability for the
air-filter arm, with a 4.1 percentage point greater reduction in
dPFV (95%CI= − 7:8 to −0:4) from the preintervention to post-
intervention winters for the air-filter arm, relative to the placebo
arm, suggesting improved airway function (Table 2). The wood-
stove changeout arm showed a 3.0 percentage point reduction for
dPFV relative to placebo (95%CI= − 7:6 to 1.6).
To further evaluate the influence of asthma severity status on
intervention efficacy, we conducted stratified analysis for inter-
vention changes to dPFV according to baseline asthma severity
(Table 3). The highest point estimate for reduction in dPFV
among the air-filter group was observed among the children with
indications of severe asthma at baseline, but no differential effect
in dPFV was evident when stratifying by severe or moderate
asthma groups. When combining those children with severe and
moderate asthma at baseline, the change in dPFV among the air-
filter group relative to placebo was similar to the primary analysis
(−4:6; 95% CI: −8:6 to −0:5). When including only primary par-
ticipants, or the child in a given home with the more severe
asthma symptoms, the change in dPFV among the air-filter group
relative to placebo was lower (−3:2; 95% CI: −7:2 to 0.80; see
Table S3). Additional sensitivity analyses, adjusting for baseline
health measure and/or ambient temperature, did not change the
effect estimates appreciably (see Table S2).
As shown previously, we observed a strong overall reduction
in indoor PM2:5 concentrations (−67%; 95% CI: −77% to
−50%) for the air-filter group relative to the placebo group, but
we observed no overall change to indoor PM2:5 for the woodstove
exchange (0.0%; 95% CI: −40%, 65%), relative to the placebo
group (Ward et al. 2017). Figure 4 shows a smoothed distribution
of log-transformed PM2:5 measures, indicating strong overlap in
preintervention and postintervention observations. Distributions
of preintervention and postintervention PM2:5 measures for the
woodstove exchange and the placebo arms were similar, consist-
ent with the previously reported findings of no change for each of
these arms. We observed strong reductions in PMc in both the fil-
ter (72%) and placebo (57%) intervention arms (Ward et al.
2017).
To further explore these changes to indoor air quality and
impact on health outcomes, we conducted post hoc analyses.
Inclusion of PM2:5 and PMc in our primary models attenuated the
estimate of the efficacy of the air filter in improving dPFV, rela-
tive to placebo (Table 4). Intervention assignment continued to
be unassociated with overall PAQLQ or the PAQLQ domain
scores when PM measures were included in analyses. However,
despite having no indication of efficacy for air-filter interventions
on PAQLQ, our exposure response analysis did indicate that
PAQLQ was associated with PM2:5 (Table 5). Because PM
measures were natural log-transformed, we report changes in each
response variable associated with a doubling of PM exposure. A
doubling of PM2:5 concentration was associated with small
declines in overall PAQLQ [−0:09 (95% CI: −0:16, −0:02)] and
emotion domain [−0:10 (95% CI: −0:18, −0:03)] scores. PM2:5
was not associated with changes in most of our assessed spirome-
try measures. However, consistent with our intent-to-treat analysis,
a doubling PM2:5 was associated with increased (i.e., worsening)
dPFV, 0.64 (95% CI: −0:05, 1.34).
Discussion
To our knowledge, this investigation is the first randomized con-
trolled trial aimed at improving asthma symptoms in children by
reducing indoor PM2:5 concentrations generated from wood-
stoves used for heating. Although the filter intervention resulted
in the anticipated reductions in indoor PM2:5 concentrations, we
did not observe treatment efficacy according to PAQLQ, our pri-
mary health outcome measure (Table 2). Given that this was a
subjective metric measured over a two-winter period, it is possi-
ble that there was a learning effect due to repeated assessment.
Indeed, we observed an improvement in the magnitude of overall
PAQLQ score from the preintervention to postintervention win-
ters in all treatment arms. Improvements also were observed in
the symptom and activity limitation PAQLQ domains for the
woodstove changeout arm and in the activity limitation PAQLQ
domains for the placebo arm (Table 2). As in analyses of the
overall PAQLQ score, no treatment effect with respect to placebo
was observed for these domains. The preintervention to postinter-
vention changes in PAQLQ were modest across all treatment
arms with most point estimate changes less than one-half unit,
whereas changes in this scale of 0.5 or more points have been
translated as a clinically relevant outcome (Juniper et al. 1996).
Assignment to the filter arm was associated with strong reduc-
tions in indoor PM2:5 concentrations in this randomized trial
(Ward et al. 2017). Reductions in coarse particles also were
observed in the filter arm and, unexpectedly, in the placebo arm.
This latter observation may explain, in part, why we did not dem-
onstrate efficacy for PAQLQ in the air-filter arm, relative to the
placebo arm. The mechanism for the observed improvement in
overall PAQLQ score, as well as in scores in the PAQLQ symp-
tom and activity limitation domains, in the woodstove arm is
unclear. As demonstrated previously, homes assigned to this
Table 2. Preintervention to postintervention mean changes [95% confidence interval (CI)]a within arm and within intervention, relative to placebo (n=114
participants).
Outcome Observations
Within group change
Placebo
Change relative to placebo
Woodstove
changeout Air filter
Woodstove
changeout Air Filter
PAQLQ
Overall 422 0.47 (0.04, 0.90) 0.22 (−0:07, 0.52) 0.29 (0.01, 0.58) 0.18 (−0:33, 0.69) −0:07 (−0:47, 0.34)
Symptoms 422 0.61 (0.13, 1.1) 0.19 (−0:14, 0.52) 0.23 (−0:09, 0.55) 0.38 (−0:19, 0.95) −0:04 (−0:49, 0.41)
Limitation of Activity 422 0.61 (0.09, 1.1) 0.23 (−0:12, 0.59) 0.48 (0.13, 0.82) 0.13 (−0:48, 0.74) −0:24 (−0:73, 0.24)
Emotion 422 0.18 (−0:25, 0.61) 0.24 (−0:06, 0.53) 0.28 (−0:01, 0.56) −0:10 (−0:61, 0.41) −0:04 (−0:44, 0.36)
Two-week spirometry monitoring
Evening FEV1 % predicted 406 −0:09 (−8:7, 8.5) −2:7 (−8:7, 3.1) −3:0 (−8:7, 2.6) 2.9 (−7:3, 13) 0.24 (−7:8, 8.3)
Morning FEV1 % predicted 408 0.96 (−7:8, 9.8) −3:4 (−9:4, 2.7) −2:6 (−8:4, 3.1) 3.6 (−6:8, 14) −0:71 (−8:9, 7.5)
Evening PEF % predicted 407 0.07 (−7:9, 8.0) −4:6 (−10, 0.98) −7:0 (−12, −1:7) 7.1 (−2:3, 16) 2.4 (−5:0, 9.9)
Morning PEF % predicted 409 1.1 (−6:9, 9.2) −3:3 (−8:9, 2.3) −6:7 (−12, −1:4) 7.8 (−1:6, 17) 3.4 (−4:1, 11)
Diurnal PEF variability, % 404 −0:8 (−4:7, 3.0) −2:0 (−4:7, 0.7) 2.2 (−0:4, 4.7) −3:0 (−7:6, 1.6) −4:1 (−7:8, −0:4)
Note: FEV1, forced expiratory volume in the first second; PAQLQ, pediatric asthma quality of life; PEF, peak expiratory flow.
aAdjusted for age and gender.
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intervention experienced no improvement in PM2:5 concentrations
or PNCs of any size; they did experience reductions in carbon
monoxide concentrations, however (Ward et al. 2017).
Peak flow measures were the secondary health measures for
this trial. We observed an improvement in dPFV, specifically a
4.1-percentage point reduction for children in the filter arm, rela-
tive to placebo. Of note, the filter arm had higher preintervention
dPFV, relative to the placebo, indicating the randomization was
not entirely successful in balancing asthma severity between
groups. Thus, we cannot rule out completely the possibility that
regression to the mean may explain, at least in part, the observed
efficacy of the filter in improving dPFV. When analyses were
limited to only those with moderate or severe persistent asthma,
the improvement in dPFV variability was similar, perhaps even
stronger for those with severe asthma. Home-based peak flow
monitoring is not well supported as a tool for clinical decision
making of asthma therapy (Kamps et al. 2001; Self et al. 2014;
Yoos et al. 2002). There also are questions about the validity of
dPFV as a clinical tool for asthmatic children, and correlation
between measures of peak expiratory flow variation and
asthma symptoms may wane over longer periods of observa-
tion (i.e., >1 year), suggesting that this measure may be less
desirable as a tool for management of asthma in children
(Brand et al. 1999). Nonetheless, dPFV does track with hyper-
responsiveness, severity of symptoms, unscheduled medical
visits, and response to bronchodilators (Brand et al. 1999;
Brouwer et al. 2006; Greenberg et al. 2012; Mortimer et al.
2001), and change in dPFV has been used as a measure that
reflects the dynamic nature of asthma (Lebowitz et al. 1997).
There is also support for using dPFV and similar measures
that reflect the natural diurnal variation of airway function and
response to exposures and treatments in randomized controlled
clinical trials (Frey and Bielicki 2017; Kaminsky et al. 2017).
Here we use dPFV in repeated two-week snapshots to indicate
short-term change and make no inferences regarding its utility
as a self-management tool. Increased dPFV has been shown to
correspond to bronchial responsiveness to nonspecific chal-
lenges (Cockcroft and Hargreave 1990; Hetzel and Clark
1980). More recently, dPFV among children with asthma was
positively associated with indoor measures of specific fungi
species (Bundy et al. 2009; Douwes et al. 2000).
Comparisons of PM and other air pollutant exposures with
dPFV among children with asthma are limited and have indicated
that pollutant effects on dPFV may be stronger among children
with mild asthma. A study of children with mild asthma in Korea
showed that dPFV increased during Asian dust events in compar-
ison with control days, with corresponding strong correlations
observed between PM10 concentrations and dPFV (Yoo et al.
2008). A panel study of children in France showed an association
between ambient SO2 and dPFV, but only among those chil-
dren with mild asthma; no associations were observed for
ambient PM13 and dPFV (Segala et al. 1998). In contrast, the
present study supports an association between smaller size
fraction PM, specifically PM2:5, and our findings of efficacy
with respect to dPFV remained robust, perhaps stronger,
when limiting the analysis to children with moderate to
severe asthma. Our observed response in dPFV among chil-
dren with moderate to severe asthma was consistent with
studies of medical intervention. Measures of PFV were found
to change favorably in response to treatment with inhaled
corticosteroids among children with moderate to severe
asthma (Simons 1997; van Essen-Zandvliet et al. 1992), but
not necessarily among children with mild asthma (Waalkens
et al. 1991).
The beneficial impact of the air-filter intervention on dPFV
was not corroborated with parallel findings in other pulmonary
function measures, i.e., morning and evening percent predicted
FEV1 and PEF. The within-group improvement in dPFV follow-
ing the air-filter intervention also was fairly small (i.e., 2 percent-
age point decline). Nevertheless, this change did indicate a
greater than 11% improvement in dPFV, relative to the baseline
winter mean in this group. Our exposure response analysis also
showed an association between elevated PM2:5 concentrations
and higher dPFV, consistent with our overall hypothesis that the
air-filter intervention improves health by improving air quality.
This study was relatively large, including more than 400 mul-
tiday exposure and health sampling visits among 114 children
with asthma from various rural regions in western Montana,
Idaho, and Alaska. Extensive information on air pollutant expo-
sures, asthma measures, and relevant covariates was ascertained
with the randomized, placebo-controlled design providing protec-
tion against confounding. However, we note several limitations.
First, to the extent possible, participating filter and placebo homes
were blinded to their treatment assignment. This blinding was not
possible for the homes receiving the woodstove intervention.
Moreover, field staff responsible for collecting exposure and
health data were not blinded, as study protocol and efficient use
of project resources required them to install intervention filter
units, replace filters at prespecified intervals, and collect home-
based health and exposure data. Quality-control procedures
were employed to protect against any potential influence
Table 3. Intervention effect on diurnal peak flow variability according to baseline asthma severity, relative to placebo, adjusted for age and gender.
Participant number Observations
Woodstove changeout Air filter
Mean change (95% CI) Mean change (95% CI)
All participants 114 404 −3:0 (−7:6, 1.6) −4:1 (−7:8, −0:4)
Severe 50 170 −1:4 (−9:3, 6.4) −4:7 (−12, 2.6)
Moderate 51 190 −5:3 (−14, 3.3) −3:8 (−9:2, 1.6)
Intermittent/mild 13 44 0.07 (−10, 10) −1:4 (−9:4, 10)
Figure 4. Kernal density plot of pre- (solid line) and postintervention
(dashed line) 48-h indoor fine particulate matter (PM2:5) by treatment arm.
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resulting from failures in blinding at the participant and investi-
gator levels, but this circumstance remains a limitation when
considered in the context of rigorous randomized controlled
trial designs. Second, performance and recording of self-
monitored PEF and FEV1 measures is highly effort dependent.
Our procedures included training participants and parents on
best-effort procedures. Although within-individual variation in
effort is likely, we expect that this error would be random rather
than systematic over the two-winter observation period, particu-
larly when considering the most robust finding, change in
dPFV, where the smallest unit of measure is percent difference
in successive PEF measures in less than 24 h (i.e., evening to
morning). Third, despite the randomized design, we observed
higher preintervention PM2:5 concentrations and poorer baseline
health in participants residing in households assigned to the
woodstove changeout arm. This arm of the study was eliminated
early due to evidence of failed efficacy with respect to reduction
of indoor PM2:5 concentrations. Had this arm continued to full
recruitment, it is possible that the baseline exposure and health
measures would have balanced with the other arms. This change
did result in larger numbers of participants allocated to the air-
filter and placebo arms, making comparison between those arms
more robust. Nevertheless, observations for the woodstove
changeout arm relative to the placebo arm should be interpreted
with caution. Fourth, the nature of the intervention strategy being
tested in this study called for between-winter, rather than within-
winter, evaluations of preintervention-to-postintervention health
changes. Asthma health and response to environmental stimuli can
change during a one-year period, particularly among adolescents
who typically have worsening symptoms during these ages. Given
the randomized design, we expect that such intra-individual
changes would not be differential with respect to treatment arm. A
crossover design was not possible in this study due to the wood-
stove changeout arm, but this approach may have been a more ro-
bust approach for evaluating within-winter filter versus placebo
effects for children with asthma. Fifth, the efficacy of the air-filter
intervention depended on the home residents operating the unit at
the recommended setting. To assess compliance, we measured
energy usage with Kilowatt meters attached at the filter units. As
demonstrated previously, mean percent compliance (i.e., actual
Kilowatt usage as a proportion of predicated Kilowatt usage) was
78%, and PM2:5 exposure reduction was robust to lower levels of
compliance (Ward et al. 2017). Sixth, although we conducted a
limited number of primary analyses, we performed nine primary
statistical tests and might observe an association due to chance
alone. As a result, we cannot rule out the possibility that the effi-
cacy of the air filter in improving dPFV is simply due to chance.
Finally, unlike patient-level clinical trials where compliant deliv-
ery of a drug or procedure accounts for 100% of the intended dose,
we must recognize that environmental intervention studies account
for some component of dose. Thus, despite substantial reductions
in indoor PM2:5 concentration following the introduction of the fil-
ter, participating children were still exposed to measurable PM2:5.
Conclusions
Biomass combustion during residential heating is an important
source of household air pollution, particularly in rural commun-
ities, and evidence-based strategies to improve indoor air quality
and asthma outcomes in such settings are needed. This random-
ized trial targeted a vulnerable population, children with asthma
who were chronically exposed to woodsmoke. The interventions
tested did not result in improvements to quality-of-life measures,
but the air-filtration device, a simple in-home intervention, was
efficacious for improving the secondary measure dPFV, an indi-
rect measure of airway hyper-responsiveness. The attenuation of
the effect when including PM in the models as well as the
exposure–response analysis provide evidence that filter-based
PM reductions contribute, at least partially, to the observed
improvements in the dPFV. This trial was conducted across sev-
eral rural communities in three states, but translation of these
findings to other settings with similarly exposed child asthma
populations would require further study and inquiry into the
Table 4. Preintervention to postintervention mean changes (95% CI) for treatments relative to placebo, adjusted for age, gender and indoor particulate matter
(n=114 participants).
Outcome
Adjusted for age, gender, PM2:5
a Adjusted for age, gender, PMcb Adjusted for age, gender, PM2:5, PMc
b
Woodstove
changeout Air filter
Woodstove
changeout Air filter
Woodstove
changeout Air filter
PAQLQ
Overall 0.18 (−0:34, 0.71) −0:15 (−0:58, 0.27) 0.20 (−0:36, 0.77) −0:13 (−0:57, 0.32) 0.20 (−0:36, 0.77) −0:21 (−0:67, 0.24)
Symptoms 0.38 (−0:20, 0.96) −0:13 (−0:60, 0.34) 0.39 (−0:23, 1.0) −0:11 (−0:60, 0.37) 0.38 (−0:23, 1.0) −0:20 (−0:70, 0.29)
Limitation of Activity 0.13 (−0:50, 0.75) −0:27 (−0:78, 0.24) 0.16 (−0:52, 0.83) −0:29 (−0:82, 0.24) 0.16 (−0:52, 0.83) −0:31 (−0:85, 0.24)
Emotion −0:10 (−0:63, 0.44) −0:14 (−0:57, 0.30) −0:06 (−0:64, 0.51) −0:08 (−0:53, 0.38) −0:06 (−0:64, 0.51) −0:19 (−0:66, 0.27)
Two-week spirometry
monitoring
Evening FEV1 % predicted 2.6 (−7:8, 13) −0:73 (−9:1, 7.7) 1.3 (−10, 13) −0:51 (−9:3, 8.3) 1.2 (−10, 13) −1:3 (−10, 7.8)
Morning FEV1 % predicted 3.2 (−7:4, 14) −1:7 (−10, 6.9) 2.2 (−9:2, 14) −2:1 (−8:4, 4.2) 2.2 (−9:3, 14) −2:4 (−11, 6.7)
Evening PEF % predicted 6.9 (−2:7, 17) 0.62 (−7:4, 8.6) 6.3 (−4:0, 16) 2.2 (−5:9, 10) 6.2 (−4:1, 17) 1.2 (−7:2, 9.7)
Morning PEF % predicted 7.7 (−2:0, 17) 1.7 (−6:3, 9.7) 7.1 (−3:1, 17) 2.5 (−5:6, 11) 7.0 (−3:2, 17) 1.8 (−6:6, 10)
Diurnal PEF variability, % −2:7 (−7:4, 2.0) −3:6 (−7:6, 0.4) −3:0 (−8:2, 2.3) −3:2 (−7:4, 1.0) −3:0 (−8:3, 2.3) −2:7 (−7:0, 1.7)
Note: FEV1 forces expiratory volume in first second; PAQLQ, Pediatric Asthma Quality of Life Questionnaire; PEF, peak expiratory flow.
aMissing observations for models with PM2:5: n=5 for PAQLQ measures; n=41 for spirometry measures.
bMissing observations for models with PMc: n=6 for PAQLQ measures; n=38 for spirometry measures.
Table 5. Effects of doubling fine fraction particulate matter (PM2:5) concen-
trations on quality of life measures and two-week spirometry monitoring,
adjusting for age, gender, and intervention assignment.
Outcome Obs Estimate 95% CI
PAQLQ
Overall 415 −0:09 (−0:16, −0:02)
Symptoms 415 −0:08 (−0:16, 0.001)
Limitation of activity activity 415 −0:07 (−0:16, 0.03)
Emotion 415 −0:10 (−0:18, −0:03)
Spirometry
Evening FEV1 398 0.55 (−0:79, 1.88)
Morning FEV1 400 0.43 (−0:90, 1.77)
Evening PEF 399 0.02 (−1:51, 1.55)
Morning PEF 401 −0:20 (−1:68, 1.28)
dPFV 396 0.64 (−0:05, 1.34)
Note: dPFV, diurnal peak flow variability; FEV1, forced expiratory volume in first sec-
ond; Obs, observations; PAQLQ, pediatric asthma quality of life Questionnaire; PEF,
peak expiratory flow.
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challenges associated with dissemination of in-home PM reduc-
tion strategies.
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